Brainstorm Cell Therapeutics Inc.

BCLI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 14, 2026 10-Q
8-K Aug 14, 2026 FORM 8-K
8-K Jul 30, 2026 FORM 8-K
4 Jul 28, 2026 OWNERSHIP DOCUMENT
4 Jul 28, 2026 OWNERSHIP DOCUMENT
3 Jun 3, 2026 OWNERSHIP DOCUMENT
EFFECT Jun 2, 2026
CORRESP Jun 1, 2026
4 May 29, 2026 OWNERSHIP DOCUMENT
4 May 29, 2026 OWNERSHIP DOCUMENT
4 May 29, 2026 OWNERSHIP DOCUMENT
4 May 29, 2026 OWNERSHIP DOCUMENT
4 May 29, 2026 OWNERSHIP DOCUMENT
8-K May 28, 2026 FORM 8-K
UPLOAD May 27, 2026
S-8 May 21, 2026 FORM S-8
S-1 May 21, 2026 S-1
4 May 20, 2026 OWNERSHIP DOCUMENT
4 May 20, 2026 OWNERSHIP DOCUMENT
4 May 20, 2026 OWNERSHIP DOCUMENT
4 May 20, 2026 OWNERSHIP DOCUMENT
4 May 20, 2026 OWNERSHIP DOCUMENT
4 May 20, 2026 OWNERSHIP DOCUMENT
8-K May 15, 2026 FORM 8-K
10-Q May 15, 2026 10-Q
← Newer Page 1 of 38 · 949 filings Older →